Article

[Short communication: prevalence of extended spectrum beta-lactamases in gram negative rods: data of 2001-2004 period].

Fatih Universitesi Tip Fakültesi, Infeksiyon Hastaliklan ve Klinik Mikrobiyoloji Anabilim Dali, Ankara.
Mikrobiyoloji bülteni (Impact Factor: 0.61). 11/2006; 40(4):355-61.
Source: PubMed

ABSTRACT This study was undertaken to determine the prevalence of extended spectrum beta-lactamase (ESBL) production by Gram negative rods (GNRs) isolated from various clinical specimens (3.240 urine, 336 pus, 277 feces, 83 blood, 38 sputum) sent to our hospital laboratory, between 2001-2004. Of isolated bacteria 71.4% were identified as Escherichia coli, 11.1% were Klebsiella spp, 4.2% were Salmonella spp, 3.7% were Pseudomonas spp, 3.5% were Proteus spp, 2.9% were Shigella spp, 2.3% were Enterobacter spp, 0.5% were Acinetobacter spp, 0.12% of each Serratia spp, and Stenotrophomonas maltophilia, 0.1% were Citrobacter spp, and one of each Providencia spp and Pantoeae spp. (0.02%). ESBL production were screened by using the double disk synergy test. Of a total of 3.974 isolates, 269 (6.8%) were found to be ESBL producers. Klebsiella spp had the highest rate (14.3%) which was followed by Enterobacter spp (8.6%) and E.coli (6.7%). All of the S.maltophilia isolates were resistant to carbapenems. One of the Shigella spp was found to be an ESBL producer, being the first case from Turkey and the fifth from the world. There was statistically significant difference in distribution of ESBL producing isolates between hospitalized (16%) and non-hospitalized patients (5%) (p<0.01). A significant increase in ESBL production rates (from 3.8% in 2001 to 10.6% in 2004) was observed over time (p<0.05). The increasing trend (about 300% in four years) in ESBL production rates, should be considered as an indicator for expansion propensity and speed of the threat against the effective treatment of infections, and possible preventive strategies should be established.

0 Bookmarks
 · 
62 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this report, we present a case of postneurosurgical meningitis due to Providencia stuartii, which was treated successfully with meropenem therapy lasting 21 days.
    Journal of clinical microbiology 10/2010; 48(12):4667-8. · 4.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the pattern and antimicrobial resistance genes of cephalosporin resistance in Shigella flexneri and Shigella dysenteriae over 9 years. Isolates of Shigella (S. flexneri, n = 119 and S. dysenteriae, n = 24) were tested for resistance to ceftriaxone and cefepime by disc diffusion, for MIC by Etest and for extended-spectrum β-lactamase (ESBL) and AmpC production. The presence of antimicrobial resistance genes was investigated by PCR using specific primers for bla(TEM), bla(OXA-1), bla(CTX-M-15), bla(SHV) and bla(CMY-2) for all the isolates. Twenty (16.8%) S. flexneri isolates were resistant/intermediately susceptible to ceftriaxone/cefepime, while all S. dysenteriae were susceptible. In S. flexneri isolates, the MIC(50) values of ceftriaxone and cefepime were found to be 0.032 and 0.125 mg/L, respectively, while their MIC(90) values were 12 and 8 mg/L, respectively. The MIC(50) and MIC(90) for S. dysenteriae were below 1 mg/L for ceftriaxone; however, for cefepime the MIC(90) was found to be 4 mg/L. Of the 20 resistant/intermediately susceptible S. flexneri isolates, 9 were positive for ESBL production and 4 for AmpC production by phenotypic tests. All 20 isolates were found to be positive for bla(TEM), 10 for bla(CTX-M-15), 8 for bla(OXA) and 7 for bla(CMY-2); none was positive for bla(SHV). We report a high level of cephalosporin resistance with high MICs and ESBL- and AmpC-mediated antibiotic resistance in Shigella from north India.
    Journal of Antimicrobial Chemotherapy 03/2012; 67(6):1347-53. · 5.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: : Providencia, unlike other enterobacteriaceae, is a lesser known causative agent of hospital-acquired and community-acquired neuroinfection. Two cases of meningitis and one patient with subdural empyema, where Providencia rettgeri was the causative agent, are reported. To the authors' knowledge, this is the first report of hospital-acquired and community-acquired meningitis or empyema caused by P rettgeri.
    The American Journal of the Medical Sciences 06/2013; · 1.33 Impact Factor